Clinical Trial Update: Pregabalin Open-Label Extension Trial in Patients With Partial Seizures [Phase 3]

View source ↗

Summary

Pfizer reports the completion of an open-label Phase 3 extension trial of pregabalin in patients with partial seizures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Partial Seizures
• Partial Seizures

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer | Conditions: Epilepsies, Partial, Epilepsy, Complex Partial | Phase 3 | Status: COMPLETED